by admin | Dec 20, 2016 | 2016, Milestones, Press Releases
Medigene AG today announced that it has granted an exclusive, worldwide license for the development and commercialization of its preclinical stage adeno-associated virus-like particles (AAVLPs) technology to 2A Pharma AB. [pdf-embedder...
by admin | Dec 20, 2016 | 2016, Funding & Investments, HPV, Milestones
2A Pharma AB today closed its first financing round, raising SEK 27 million from private angel investors. This new capital will enable us to take our first project, the AAVLP-HPV vaccine, through to the end of phase I clinical studies. We are grateful for our...
by admin | Dec 12, 2016 | 2016, Milestones
2A Pharma AB was incorporated in Sweden on 12 December 2016. Søren Nielsen, CEO: “This marks the formal beginning of a new exciting venture and the team is very excited about the journey ahead.”
Recent Comments